Sectoral Asset Management Inc Bridge Bio Pharma, Inc. Transaction History

Sectoral Asset Management Inc

$203 Million
Q1 2024

A detailed history of Sectoral Asset Management Inc transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Sectoral Asset Management Inc holds 16,105 shares of BBIO stock, worth $407,939. This represents 0.24% of its overall portfolio holdings.

Number of Shares

16,105

Previous 12,955 24.31%

Holding current value

$407,939

Previous $522,000 4.79%

% of portfolio

0.24%

Previous 0.24%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$27.35 - $40.45 $86,152 - $127,417	3,150 Added 24.31%	16,105 $497,000
Q4 2023 Feb 14, 2024	SELL	$24.02 - $43.89 $4.02 Million - $7.34 Million	-167,240 Reduced 92.81%	12,955 $522,000
Q3 2023 Nov 14, 2023	BUY	$16.89 - $35.01 $3.04 Million - $6.31 Million	180,195 New	180,195 $4.75 Million
Q1 2022 May 10, 2022	SELL	$7.34 - $17.16 $2.08 Million - $4.86 Million	-282,950 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$11.38 - $53.41 $2.16 Million - $10.1 Million	-190,000 Reduced 40.17%	282,950 $4.72 Million

Q3 2021 Nov 15, 2021	BUY	$46.87 - $64.24 $6.89 Million - $9.45 Million	147,100 Added 45.14%	472,950 $22.2 Million
Q2 2021 Aug 16, 2021	BUY	$46.47 - $63.93 $6.63 Million - $9.13 Million	142,750 Added 77.96%	325,850 $19.9 Million
Q1 2021 May 14, 2021	BUY	$55.47 - $72.35 $9.82 Million - $12.8 Million	177,100 Added 2951.67%	183,100 $11.3 Million
Q4 2020 Feb 12, 2021	BUY	$38.38 - $71.11 $230,280 - $426,660	6,000 New	6,000 $427,000

Others Institutions Holding BBIO

# of Institutions

284

Shares Held

170M

Call Options Held

7.41M

Put Options Held

2.61M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.76B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sectoral Asset Management Inc with notifications on news.

Account

Sectoral Asset Management Inc Bridge Bio Pharma, Inc. Transaction History